Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
ECO
Jun 28, 2024, 14:34 |
Blog
María Natalia Gandur Quiroga: Imfinzi Shows Significant Survival Benefits in NIAGARA Phase III Trial
María Natalia Gandur Quiroga shared on LinkedIn: . "Imfinzi Shows Significant Survival Benefits in NIAGARA…
Jun 28, 2024, 14:08 |
Blog
Reflections from NAI2024 by Wafik S. El-Deiry
Recently The National Academy of Inventors (NAI) organized its 13th Annual Conference. The NAI aims…
Jun 28, 2024, 14:06 |
Blog
Vincent Rajkumar: Cure is a simple word. But there is confusion when it comes to cancer
Vincent Rajkumar shared a post on X: “Cure is a simple word. But there is…
Jun 28, 2024, 13:41 |
Insight
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Agenus shared on their X page: "New data from the NEST clinical trial was presented…
Jun 28, 2024, 13:17 |
Blog
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
Zainab Shinkafi-Bagudu shared a post on LinkedIn: . "Following…
Jun 28, 2024, 13:00 |
Insight
Cathy Eng: Agenus with very promising data in early MSI-s/MSI-H colon cancer
Cathy Eng shared on X/Twitter: "Bot/Bal immunotherapy in colon cancer NEST 1/2. Agenus with very…
Jun 28, 2024, 12:50 |
Insight
AI model may yield better outcomes for prostate cancer - UCLA Health
Using AI assistance for identifying cancerous tissue was 45 times more accurate than doctors’ measurements…
Jun 28, 2024, 12:46 |
Blog
The partnership between UICC and Tradition Genève 1959 will enable access to early breast cancer detection services for women
Union for International Cancer Control (UICC) shared a post by Tradition Genève 1959 on LinkedIn,…
Jun 28, 2024, 12:37 |
Blog
Devika Das: A whole new Pandora’s box of toxicities with the advent of check point inhibitors
Devika Das, Medical Director at Parexel, recently shared on LinkedIn: . “It definitely takes a…
Jun 28, 2024, 11:08 |
Insight
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results Authors: E. Felip, B.C.…
184
185
186
187
188
All:
4358
Posts:
1851 - 1860
Peyo the Therapy Horse: Comforting Terminally Ill Patients Through Horse Therapy.
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Small Bowel Cancer: Symptoms & Causes, Types, Diagnosis and Treatment
Mikkael A. Sekeres, Candidate for Secretary of ASH
Paolo Tarantino: Top 10 Breast Cancer abstracts from ESMO2024
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube